We believe, that as the transplant recipients with graft steatosis share most of risk factors associated with NAFLD in general population, particularly high prevalence of risk alleles of PNPLA3 rs738409 and TM6SF2 rs58542926 gene polymorphism in corresponding donors, higher BMI, higher triglycerides plasma concentration and diabetes mellitus [4,16,17], our finding could probably, with caution, also apply to regular NAFLD/NASH patients. Here, TM6SF2 is linked to steatosis.